Racial/Ethnic Differences in Framingham Risk Score in an NHANES Cohort
Ashley Farokhrouz, Rodney G. Bowden, Kathleen A. Richardson, Tanvir Ahmed, Jaimala Kishore
Cardiovascular risk assessment & health disparities
Peer-reviewed · Open access · ISSN 2474-3585 · Published by Open Access Pub
Research that reduces risk before disease takes hold — clinical prevention, screening and early detection, behavioural and community health, and the systems and policies that shift risk across whole populations. Work that focuses on treatment without a prevention or public-health dimension may be out of scope.
Scope
The Journal of Preventive Medicine and Care (JPMC) publishes peer-reviewed research in preventive medicine and public health. A manuscript belongs here if it reports a measurable prevention outcome, or a finding with a clear implication for preventive practice, preventive care delivery or prevention policy. Work is assessed against the four bands of the prevention continuum below.
Risk reduction, immunisation, health promotion and behavioural intervention in populations that are not yet affected.
Screening programmes and uptake, diagnostic pathways, and timely intervention that slows or halts progression.
Care models and preventive management that reduce complications, recurrence and avoidable deterioration.
Population-level strategies, health-system and policy measures that shift the distribution of risk and close gaps in access.
Cardiometabolic risk reduction, chronic disease prevention, preventive care in primary care settings, and preventive management across the lifespan.
Cancer and chronic disease screening, uptake and participation, population outreach, and prevention-focused clinical workflows.
Behaviour change and lifestyle medicine, nutrition, physical activity, tobacco control, community-based prevention, and health education.
Implementation science and quality improvement, occupational and environmental prevention, health economics of prevention, social determinants and health disparities.
Scope boundary
The journal states its limit in one sentence, in the Instructions for Authors: “If your work focuses on treatment without a prevention or public health dimension, it may be out of scope.” The four manuscript categories below are the ones JPMC lists, with the journal’s own limits — a design that does not appear here has no category to be submitted under.
3,000-6,000 words. Structured abstract of 300 words; up to 10 figures and tables.
4,000-8,000 words. Structured abstract of 300 words; up to 12 figures and tables.
2,500-5,000 words. Structured abstract of 250 words; up to 8 figures and tables.
1,500-2,500 words. Unstructured abstract of 200 words; up to 4 figures and tables.
Unsure whether a study fits? The decisive question is whether the conclusion changes what someone would do to prevent disease, detect it earlier, or reduce risk in a population. The Aims & Scope page asks authors who are uncertain to contact the editorial office before submitting.
Scope priorities, settings and populations are set out on the Aims & Scope page; category limits, structure and reporting standards are in the Instructions for Authors.
Published research
Peer-reviewed articles from the JPMC archive, chosen to show the range of prevention evidence the journal publishes rather than simply the most recent deposits. Each links to the full text; every article is open access under CC BY 4.0 and carries a registered Crossref DOI.
Ashley Farokhrouz, Rodney G. Bowden, Kathleen A. Richardson, Tanvir Ahmed, Jaimala Kishore
Cardiovascular risk assessment & health disparities
Adesoji E. Adetona, Kayode O. Osungbade, Oluwaseun O. Akinyemi, Taiwo A. Obembe
Cancer screening uptake & early detection
Charles Njumkeng, Elvis T. Amin, Denis Zofou, Jane-Francis K. T. Akoachere, Patrick A. Njukeng
Antimicrobial resistance & community health protection
Sanjay Agrawal, Sanjeev M. Chaudhary, Sanjay S. Kubde, Manjusha Dhoble, Moin Shaikh
Cardiometabolic risk factors in an occupational cohort
Ahmet Doğan, Hüseyin Dağ, Habip Gedik, Kemal Pişmişoğlu
Immunisation practice & vaccine-preventable disease
John Elvis Hagan Jr., Christiana Nsiah-Asamoah, Thomas Hormenu, Dietmar Pollmann, Thomas Schack
Behavioural intervention & obesity prevention
JPMC publishes continuously: an article is released as soon as it completes peer review and production, and is assigned to an issue at that point. Issue Volume 3, Issue 3 is the most recently assigned.
The record
Every figure below is counted from the journal’s own published corpus each time this page loads, so it cannot drift from what the archive serves. JPMC publishes only numbers a reader can reproduce from the record itself — open the archive and count.
Editorial oversight
Manuscripts are handled by an international editorial board of 11 members working in preventive medicine, public health, nursing and prevention-focused clinical practice. Four are shown here; the affiliation given for each was confirmed against the ORCID public registry or the institution’s own records, and the full board is listed with research interests and profiles.
Associate Professor of Community Health Sciences
Boston University School of Public Health, United States
Chronic disease prevention, the social and structural determinants of health, and health communication.
ORCID 0000-0002-7019-5072
Professor of Pediatrics
UT Southwestern Medical Center, United States
Epidemiology of paediatric blood pressure and cholesterol disorders and their role in adult cardiovascular disease; preventive cardiology.
Associate Research Professor, Regional Research Institute
Portland State University School of Social Work, United States
Interpersonal violence prevention among adults with disabilities; community-engaged research and programme evaluation.
Professor, College of Nursing
Yonsei University, Republic of Korea
Behaviour-based interventions and cognitive training for older adults with mild cognitive impairment in rural communities.
ORCID 0000-0003-3719-0111
Peer review
Review is Single-blind (double-blind on request). Every submission passes through the same four stages, and the decision rests on the science.
Every submission is screened by an editor for scope fit, ethical compliance and completeness before it goes any further.
In-scope manuscripts are assessed by subject-matter reviewers in preventive medicine, public health and care delivery. Review is Single-blind (double-blind on request).
An editor weighs the reviews against methodological rigour, scope alignment and prevention relevance, and issues a clear decision category.
Authors receive the reviews with explicit revision guidance. Decisions may be appealed with an evidence-based rationale and are reviewed by senior editors.
Editorial decisions are based on scientific merit and are made independently of article processing charges, membership, paid language editing, or any other payment or service. No fee, service or role confers an advantage in the review or acceptance of a manuscript.
The complete policy set is on the Editorial Policies page.
Research integrity
The requirements below apply to every submission and are published in full on the journal’s policy pages. JPMC follows COPE guidance on publication ethics, misconduct and authorship disputes.
Studies involving human participants require documented institutional review board approval and informed consent.
Authors and reviewers disclose financial and non-financial competing interests; funding sources and sponsor roles are reported.
All submissions are screened for plagiarism before review.
Data availability statements are required where applicable, and clinical trials should be registered with a protocol identifier.
Errors identified after publication are addressed by correction or retraction. Suspected misconduct is handled under COPE guidance; authorship disputes are managed according to international standards.
Editorial decisions rest on scientific merit and are independent of funding, fees, membership or any paid service.
Open access & charges
One charge, one figure, stated once. Nothing is payable to submit, and nothing is payable if a manuscript is declined.
Discovery & identifiers
Every service listed below can be checked, and the checkable ones are linked so a reader can confirm them in a single click rather than take the journal’s word for it. Nothing appears here that JPMC cannot evidence; the journal’s full coverage position is answered in the questions further down this page.
Submission
Four checks that decide most outcomes, and the manuscript categories JPMC considers.
State, in the abstract, what the finding changes about preventing disease, detecting it earlier, or reducing risk. This is the first thing an editor screens for.
The journal asks authors to use the established guideline relevant to the study design: CONSORT for trials and interventions; STROBE for observational studies; PRISMA for reviews and evidence syntheses; TIDieR for intervention reporting; SQUIRE for quality improvement studies.
Ethics approval and consent statements, competing-interest and funding declarations, a data availability statement, and a trial registration identifier where one applies.
Follow the manuscript structure, reference style and file requirements in the Instructions for Authors, then submit through the journal’s submission page.
3,000-6,000 words. Structured abstract of 300 words; up to 10 figures and tables.
4,000-8,000 words. Structured abstract of 300 words; up to 12 figures and tables.
2,500-5,000 words. Structured abstract of 250 words; up to 8 figures and tables.
1,500-2,500 words. Unstructured abstract of 200 words; up to 4 figures and tables.
Questions
If your study shows how risk can be reduced, disease detected earlier, or prevention delivered better — in a clinic, a workplace, a community or a whole population — the editors would like to see it.
Submit a manuscriptJournal of Preventive Medicine and Care · ISSN 2474-3585 · Published by Open Access Pub · Editorial policies · Contact the editorial office
Journal index